siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway

被引:116
作者
Miyawaki-Shimizu, K
Predescu, D
Shimizu, J
Broman, M
Predescu, S
Malik, AB
机构
[1] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Lung & Vasc Biol Ctr, Chicago, IL 60612 USA
关键词
caveolae; interendothelial junction; nitric oxide;
D O I
10.1152/ajplung.00292.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Caveolin-1, the principal integral membrane protein of caveolae, has been implicated in regulating the structural integrity of caveolae, vesicular trafficking, and signal transduction. Although the functions of caveolin-1 are beginning to be explored in caveolin-1(-/-) mice, these results are confounded by unknown compensatory mechanisms and the development of pulmonary hypertension, cardiomyopathy, and lung fibrosis. To address the role of caveolin-1 in regulating lung vascular permeability, in the present study we used small interfering RNA ( siRNA) to knock down caveolin-1 expression in mouse lung endothelia in vivo. Intravenous injection of siRNA against caveolin-1 mRNA incorporated in liposomes selectively reduced the expression of caveolin-1 by similar to 90% within 96 h of injection compared with wild-type mice. We observed the concomitant disappearance of caveolae in lung vessel endothelia and dilated interendothelial junctions (IEJs) as well as increased lung vascular permeability to albumin via IEJs. The reduced caveolin-1 expression also resulted in increased plasma nitric oxide concentration. The nitric oxide synthase inhibitor L-NAME, in part, blocked the increased vascular albumin permeability. These morphological and functional effects of caveolin-1 knockdown were reversible within 168 h after siRNA injection, corresponding to the restoration of caveolin-1 expression. Thus our results demonstrate the essential requirement of caveolin-1 in mediating the formation of caveolae in endothelial cells in vivo and in negatively regulating IEJ permeability.
引用
收藏
页码:L405 / L413
页数:9
相关论文
共 53 条
[1]   POTOCYTOSIS - SEQUESTRATION AND TRANSPORT OF SMALL MOLECULES BY CAVEOLAE [J].
ANDERSON, RGW ;
KAMEN, BA ;
ROTHBERG, KG ;
LACEY, SW .
SCIENCE, 1992, 255 (5043) :410-411
[2]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[3]   Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis [J].
Bauer, PM ;
Yu, J ;
Chen, Y ;
Hickey, R ;
Bernatchez, PN ;
Looft-Wilson, R ;
Huang, Y ;
Giordano, F ;
Stan, RV ;
Sessa, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (01) :204-209
[4]   Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides [J].
Bernatchez, PN ;
Bauer, PM ;
Yu, J ;
Prendergast, JS ;
He, PN ;
Sessa, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :761-766
[5]   Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol [J].
Bist, A ;
Fielding, PE ;
Fielding, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10693-10698
[6]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[7]   Role of caveolae and caveolins in health and disease [J].
Cohen, AW ;
Hnasko, R ;
Schubert, W ;
Lisanti, MP .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1341-1379
[8]   Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue [J].
Cohen, AW ;
Razani, B ;
Wang, XB ;
Combs, TP ;
Williams, TM ;
Scherer, PE ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (01) :C222-C235
[9]   Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts [J].
Cohen, AW ;
Park, DS ;
Woodman, SE ;
Williams, TM ;
Chandra, M ;
Shirani, J ;
De Souza, AP ;
Kitsis, RN ;
Russell, RG ;
Weiss, LM ;
Tang, BY ;
Jelicks, LA ;
Factor, SM ;
Shtutin, V ;
Tanowitz, HB ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02) :C457-C474
[10]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452